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Background:  Right heart thrombi, particularly when mobile, are associated with significantly high risk of early mortality in patients with 
acute pulmonary embolism, up to 80-100% when left untreated. Urgent therapy is mandatory. However, guidelines recommendations for 
the treatment of choice, thrombolysis or embolectomy, are controversial, as data from controlled trials is still scarce.
case:  A 70-year-old man presented with severe dyspnea, chest pain and syncope. His medical history included hypertension and 
diabetes. Physical examination showed signs of low cardiac output, with low blood pressure of 100/50 mmHg in both arms, sinus 
tachycardia, cyanosis and moderate hypoxemia (SpO2=86%) and no pulmonary congestion, with jugular venous distension and grade 4 of 
6 systolic murmur in the tricuspid area. NTproBNP level was increased (4,624 pg/ml). ECG showed right ventricular (RV) ischemia.
decision Making:  Echocardiography showed normal aorta and left ventricular function, which ruled out aortic dissection and acute 
coronary syndrome. There was a very large and mobile thrombus emerging from the right atrium, going through tricuspid valve into RV and 
into the pulmonary artery. The patient also had impaired RV systolic function, severe tricuspid regurgitation, severe pulmonary hypertension 
and right deep vein thrombosis. Time was crucial and thrombolisys with rtPA was performed without further diagnostic tests or delay until 
surgical embolectomy, to prevent cardiogenic shock for this high-risk patient. There was a rapid clinical improvement along with a massive 
regression in right heart and venous thrombosis just six hours after thrombolisys, confirmed by cardiac and venous ultrasound. Contrast 
spiral computed tomography performed the next day showed only segmental left inferior pulmonary arteries thrombosis. ECG signs of RV 
ischemia partially regressed within 24 hours, while RV systolic function significantly improved in one week.
conclusion:  This case demonstrates the importance of individual clinical decision making for mobile right heart thrombosis treatment, in 
the absence of strong evidence based data for choosing the right therapy in this life-threatening condition.
